Biogen
BIIB
#587
Rank
$32.00 B
Marketcap
$220.21
Share price
-0.41%
Change (1 day)
-19.02%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Operating Margin for Biogen (BIIB)

Operating Margin as of February 2024 (TTM): 31.30%

According to Biogen's latest financial reports and stock price the company's current Operating Margin is 31.30%. At the end of 2022 the company had an Operating Margin of 28.52%.

Operating Margin history for Biogen from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202228.52%11.55%
202125.57%-22.68%
202033.07%-32.42%
201948.93%9.7%
201844.61%-0.96%
201745.04%-8.79%
201649.38%5.98%
201546.59%15.42%
201440.37%12.37%
201335.92%7.78%
201233.33%-3.51%
201134.54%28.67%
201026.84%-14.14%
200931.26%6.67%
200829.31%-2.26%
200729.99%13.87%
200626.33%69.75%
200515.51%198.31%
20045.20%-104.08%
2003-127.42%-622.34%
200224.39%-29.34%
200134.52%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.88%-26.90%๐Ÿ‡บ๐Ÿ‡ธ USA
34.61% 10.58%๐Ÿ‡บ๐Ÿ‡ธ USA
18.65%-40.42%๐Ÿ‡บ๐Ÿ‡ธ USA
34.59% 10.51%๐Ÿ‡บ๐Ÿ‡ธ USA
18.21%-41.82%๐Ÿ‡ซ๐Ÿ‡ท France
26.84%-14.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-94.58%-402.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.50%-369.97%๐Ÿ‡บ๐Ÿ‡ธ USA
23.93%-23.55%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-19.26%-161.53%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.